FDA Clears Gen-Probe's HBV Assay; Approval Triggers $10M Milestone Payment | GenomeWeb
NEW YORK (GenomeWeb News) – The US Food and Drug Administration has approved Gen-Probe’s Procleix Ultrio assay to screen donated blood for hepatitis B, the company said Wednesday.
 
GenProbe said the FDA's approval triggers a $10 million milestone payment from the Novartis subsidiary Chiron, which is the test’s worldwide distributor.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.